Murine model for Fusarium oxysporum invasive fusariosis reveals organ-specific structures for dissemination and long-term persistence

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Schäfer, Katja ^a   Di Pietro, Antonio ^a   Gow, Neil A R ^b   MacCallum, Donna ^b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHLAMYDOSPORE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE SEVERITY; EYE INFECTION; FEMALE; FUNGAL COLONIZATION; FUNGAL STRUCTURES; FUNGUS GROWTH; FUNGUS HYPHAE; FUNGUS IDENTIFICATION; FUSARIOSIS; FUSARIUM OXYSPORUM; GROWTH RATE; HEART DISEASE; HEPATITIS; HOST PATHOGEN INTERACTION; INOCULATION; KIDNEY INFECTION; LUNG INFECTION; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; SKIN INFECTION; SKIN NECROSIS; SPLEEN DISEASE; SYSTEMIC MYCOSIS; THROMBOSIS;

ANIMALS; COLONY COUNT, MICROBIAL; DISEASE MODELS, ANIMAL; EYE; FEMALE; FUSARIOSIS; FUSARIUM; IMMUNOCOMPROMISED HOST; IMMUNOSUPPRESSIVE AGENTS; MICE; TAIL; THROMBOSIS;

EID: 84896130843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089920     Document Type: Article

References (45)

1. Naggie S, Perfect JR (2009) Molds: hyalohyphomycosis, phaeohyphomycosis, and zygomycosis. Clin Chest Med 30: 337-353, vii-viii.
2. Dignani MC, Anaissie E (2004) Human fusariosis. Clin Microbiol Infect 10 Suppl 1: 67-75. (Pubitemid 38379952)
3. Nucci M, Anaissie E (2007) Fusarium infections in immunocompromised patients. Clin Microbiol Rev 20: 695-704. (Pubitemid 47623773)
4. Rotowa NA, Shadomy HJ, Shadomy S (1990) In vitro activities of polyene and imidazole antifungal agents against unusual opportunistic fungal pathogens. Mycoses 33: 203-211. (Pubitemid 20344245)
5. Anaissie E, Paetznick V, Proffitt R, Adler-Moore J, Bodey GP (1991) Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Eur J Clin Microbiol Infect Dis 10: 665-668.
6. Reuben A, Anaissie E, Nelson PE, Hashem R, Legrand C, et al. (1989) Antifungal susceptibility of 44 clinical isolates of Fusarium species determined by using a broth microdilution method. Antimicrob Agents Chemother 33: 1647-1649. (Pubitemid 19228037)
7. de Pauw BE, Meunier F (1999) The challenge of invasive fungal infection. Chemotherapy 45 Suppl 1: 1-14.
8. Walsh TJ, Hiemenz JW, Anaissie E (1996) Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients. Infect Dis Clin North Am 10: 365-400. (Pubitemid 26248591)
9. Nucci M, Anaissie E (2002) Cutaneous infection by Fusarium species in healthy and immunocompromised hosts: implications for diagnosis and management. Clin Infect Dis 35: 909-920. (Pubitemid 35178307)
10. Fan Y, Willems L, Leboeuf C, Li W, Lacroix C, et al. (2010) Skin Microvascular Thrombosis in Fusarium Infection in Two Early Biopsied Cases. Case Rep Dermatol 2: 76-81.
11. Nucci M, Anaissie E (2006) Emerging fungi. Infect Dis Clin North Am 20: 563-579. (Pubitemid 44389926)
12. Boutati EI, Anaissie EJ (1997) Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years' experience at a cancer center and implications for management. Blood 90: 999-1008. (Pubitemid 27314133)
13. Beckman CH, editor (1987) The nature of wilt disease of plants. 175 p.
14. Guarro J, Gene J (1995) Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 14: 741-754.
15. Low CY, Rotstein C (2011) Emerging fungal infections in immunocompromised patients. F1000 Med Rep 3: 14.
16. Odds FC, Van Gerven F, Espinel-Ingroff A, Bartlett MS, Ghannoum MA, et al. (1998) Evaluation of possible correlations between antifungal susceptibilities of filamentous fungi in vitro and antifungal treatment outcomes in animal infection models. Antimicrob Agents Chemother 42: 282-288. (Pubitemid 28114432)
17. Nelson PE, Dignani MC, Anaissie EJ (1994) Taxonomy, biology, and clinical aspects of Fusarium species. Clin Microbiol Rev 7: 479-504. (Pubitemid 24317876)
18. Silveira FP, Husain S (2007) Fungal infections in solid organ transplantation. Med Mycol 45: 305-320. (Pubitemid 46839801)
19. Ortoneda M, Guarro J, Madrid MP, Caracuel Z, Roncero MI, et al. (2004) Fusarium oxysporum as a multihost model for the genetic dissection of fungal virulence in plants and mammals. Infect Immun 72: 1760-1766. (Pubitemid 38263801)
20. Prados-Rosales RC, Roldan-Rodriguez R, Serena C, Lopez-Berges MS, Guarro J, et al. (2012) A PR-1-like protein of Fusarium oxysporum functions in virulence on mammalian hosts. J Biol Chem 287: 21970-21979.
21. Martinez-Rocha AL, Roncero MI, Lopez-Ramirez A, Marine M, Guarro J, et al. (2008) Rho1 has distinct functions in morphogenesis, cell wall biosynthesis and virulence of Fusarium oxysporum. Cell Microbiol 10: 1339-1351. (Pubitemid 351663924)
22. Lopez-Berges MS, Capilla J, Turra D, Schafferer L, Matthijs S, et al. (2012) HapX-mediated iron homeostasis is essential for rhizosphere competence and virulence of the soilborne pathogen Fusarium oxysporum . Plant Cell 24: 3805-3822.
23. Lopez-Berges MS, Hera C, Sulyok M, Schafer K, Capilla J, et al. (2013) The velvet complex governs mycotoxin production and virulence of Fusarium oxysporum on plant and mammalian hosts. Mol Microbiol 87: 49-65.
24. Di Pietro A, Roncero MI (1998) Cloning, expression, and role in pathogenicity of pg1 encoding the major extracellular endopolygalacturonase of the vascular wilt pathogen Fusarium oxysporum . Mol Plant Microbe Interact 11: 91-98. (Pubitemid 28065700)
25. Nelson PE, Dignani MC, Anaissie EJ (1994) Taxonomy, biology, and clinical aspect of Fusarium species. Clin Microbiol Rev, 7: 479-504. (Pubitemid 24317876)
26. Patterson TF, Mackool BT, Gilman MD, Piris A (2009) Case records of the Massachusetts General Hospital. Case 22-2009. A 59-year-old man with skin and pulmonary lesions after chemotherapy for leukemia [corrected]. N Engl J Med 361: 287-296.
27. Couteaudier Y, Alabouvette C (1990) Survival and inoculum potential of conidia and chlamydospores of Fusarium oxysporum f.sp. lini in soil. Can J Microbiol 36: 551-556. (Pubitemid 20350402)
28. Kono Y, Yamamoto H, Takeuchi M, Komada H (1995) Alterations in superoxide dismutase and catalase in Fusarium oxysporum during starvation-induced differentiation. Biochim Biophys Acta 1268: 35-40.
29. Nelson PE, editor (1981) Fungal Wilt Diseases of Plants: Life cycle and epidemiology of Fusarium oxysporum: Academic Press, Inc., New York, N.Y. p. 51-80. p.
30. Schippers B, van Eck WH, editor (1981) Formation and survival of chlamydospores in Fusarium . The Pennsylvania State University Press, University Park. ed: In Neson PE, Toussoun TA, Cook RJ (ed.). p. 250-260 p.
31. Stevenson IL, Becker SA (1972) The fine structure and development of chlamydospores of Fusarium oxysporum. Can J Microbiol 18: 997-1002.
32. Sheppard DC, Marr KA, Fredricks DN, Chiang LY, Doedt T, et al. (2006) Comparison of three methodologies for the determination of pulmonary fungal burden in experimental murine aspergillosis. Clin Microbiol Infect 12: 376-380. (Pubitemid 43337528)
33. Musher B, Fredricks D, Leisenring W, Balajee SA, Smith C, et al. (2004) Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid. J Clin Microbiol 42: 5517-5522. (Pubitemid 39664330)
34. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, et al. (2004) Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 190: 641-649. (Pubitemid 38982107)
35. Gonzalez GM, Marquez J, Trevino-Rangel Rde J, Palma-Nicolas JP, Garza- Gonzalez E, et al. (2013) Murine model of disseminated fusariosis: evaluation of the fungal burden by traditional CFU and quantitative PCR. Mycopathologia 176: 219-224.
36. Zhao Y, Park S, Warn P, Shrief R, Harrison E, et al. (2010) Detection of Aspergillus fumigatus in a rat model of invasive pulmonary aspergillosis by real-time nucleic acid sequence-based amplification. J Clin Microbiol 48: 1378-1383.
37. Bodey GP, Boktour M, Mays S, Duvic M, Kontoyiannis D, et al. (2002) Skin lesions associated with Fusarium infection. J Am Acad Dermatol 47: 659-666. (Pubitemid 35239325)
38. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R (2003) Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol 51: 315-321. (Pubitemid 38082261)
39. Gugnani HC, Talwar RS, Njoku-Obi AN, Kodilinye HC (1976) Mycotic keratitis in Nigeria. A study of 21 cases. Br J Ophthalmol 60: 607-613.
40. Foster CS (1992) Fungal keratitis. Infect Dis Clin North Am 6: 851-857.
41. Liesegang TJ, Forster RK (1980) Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 90: 38-47. (Pubitemid 10033930)
42. Ishibashi Y (1982) [Keratomycosis in Japan reported from 1976 to 1980]. Nihon Ganka Gakkai Zasshi 86: 651-656.
43. Jones DB, Sexton R, Rebell G (1970) Mycotic keratitis in South Florida: a review of thirty-nine cases. Trans Ophthalmol Soc U K 89: 781-797.
44. Polack FM, Kaufman HE, Newmark E (1971) Keratomycosis. Medical and surgical treatment. Arch Ophthalmol 85: 410-416.
45. Mayayo E, Pujol I, Guarro J (1999) Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol 48: 363-366. (Pubitemid 29478863)